Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

 

The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
publication date: Dec 3, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

The NCI Board of Scientific Advisors approved a cooperative agreement to support the biospecimen banks for the NCI clinical trials network.

The agreement aims to consolidate the current cooperative group banks into a National Clinical Trials Network biospecimen banking networks for four adult groups and one pediatric group.

The RFA received unanimous approval at their Nov. 7 meeting.



To access this members-only content, please log in.

If you're not a subscriber why not join today?

If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Letter